HLB PANAGENE Co., Ltd. engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips. The firm operates through the PNA Materials and Diagnostic Product business divisions. Its products are marketed as PANAMutyper, PNAClamp, PANArray, PANA qPCR, PNA Oligo and Monomer. The company was founded on April 16, 2001 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company